Search results
Results from the WOW.Com Content Network
CRISPR Therapeutics has a $3.9 billion market cap at recent prices, but the stock is less expensive than it looks on the surface. With a big cash cushion and a lack of debt, its enterprise value ...
CRSP Market Cap data by YCharts. 3. Intensive competition. The success of CRISPR Therapeutics will depend on its ability to bring multiple new drugs to the market to support a more viable business ...
CRISPR Therapeutics (NASDAQ: CRSP), ... Its price in the U.S. is $2.2 million. Its total addressable market includes about 35,000 patients in the U.S. and Europe and an additional 23,000 in Saudi ...
The next two years may be a bit financially tight for CRISPR Therapeutics, which represents a risk for those who buy the stock now. As of the second quarter, it has about $484 million in cash ...
For premium support please call: 800-290-4726 more ways to reach us
There's a lot of growth on the way, and soon. For premium support please call: 800-290-4726 more ways to reach us
The gene-editing therapy specialist is rising in prominence. For premium support please call: 800-290-4726 more ways to reach us
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $114.74, moving -0.92% from the previous trading session. CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You ...